Designing cancer-inspired scaffolds for neural repair

NIH RePORTER · NIH · R21 · $190,465 · view on reporter.nih.gov ↗

Abstract

Traumatic neural injury causes debilitating and permanent paralysis, in part because chronic inflammation prevents the wound from healing. Our over-arching goal is to design biomaterial strategies for neural repair that instruct remodeling of glial cells – important neural cells capable of regulating inflammation and tissue regeneration. Glial cells become reactive after injury, propagating and maintaining the pro-inflammatory environment leading to chronic inflammation. Recent studies have shown that these glial cells, namely astrocytes and microglia, can adapt phenotypes for neuroprotection and repair given the right stimuli. In our own work using a patient-designed model of brain cancer, we found introduction of glial cells to cancer cells significantly alters glial cell reactivity. Cancer cells are known to express matrix proteins and cell-surface glycans that train local cells, including glial cells, to adopt anti-inflammatory phenotypes. We hypothesize that factors produced by cancer cells may inform design of new materials to retrain reactive glial cells to suppress inflammation and promote repair after injury. To addressing these hypotheses, we will in this proposal 1) characterize expression of extracellular matrix proteins and cell-surface glycans from several patient-derived brain cancer cells, 2) from this characterization identify potential candidate molecules regulating glial cell phenotype, and 3) screen for ligand combinations inducing anti-inflammatory glial phenotypes under normal and inflamed conditions. This approach will leverage patient-derived glioblastoma cancer cells, two high throughput biomaterial platforms, and programmable ligands for ‘click’ chemistry to establish the therapeutic potential of using cancer to inform strategies for tissue regeneration. Ultimately, understanding how brain cancer dictates behavior of neural cells, biasing them toward anti-inflammatory phenotypes, will enable development of materials to instruct remodeling of the injury environment and promote repair, with possibly widespread applications in a number of tissues and pathologies.

Key facts

NIH application ID
10376778
Project number
5R21EB031435-02
Recipient
UNIVERSITY OF MASSACHUSETTS AMHERST
Principal Investigator
Robert Chase Cornelison
Activity code
R21
Funding institute
NIH
Fiscal year
2022
Award amount
$190,465
Award type
5
Project period
2021-04-01 → 2024-01-31